Spencer Craig
Medical · Roswell, GANPI 1376001362
Payments from drug & device makers
Across 265 payments — averaging $30.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Galderma Laboratories, L.p.$1K
- Sanofi$1K
- Novartis$499
- Pfizer$466
- Johnson & Johnson$462
- plus $3K from 19 others
What the payments were for
- Food & beverage$7,70595%
- Education$3655%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 50 | $1,365 |
| Galderma Laboratories, L.p. | 16 | $1,043 |
| Sanofi | 43 | $1,018 |
| Novartis | 12 | $499 |
| Pfizer | 19 | $466 |
| Johnson & Johnson | 13 | $462 |
| Incyte Corporation | 10 | $403 |
| E.r. Squibb & Sons, L.L.C. | 13 | $401 |
| Regeneron Healthcare Solutions, Inc. | 11 | $376 |
| Dermavant Sciences, Inc. | 10 | $296 |
| VYNE Pharmaceuticals Inc. | 6 | $295 |
| Sun Pharmaceutical Industries Inc. | 11 | $272 |
| LEO Pharma Inc. | 7 | $161 |
| Mayne Pharma Commercial LLC | 16 | $157 |
| Arcutis Biotherapeutics, Inc. | 3 | $151 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $149 |
| UCB, Inc. | 7 | $142 |
| Almirall LLC | 4 | $99 |
| Organon | 1 | $97 |
| Amgen | 4 | $89 |
| Lilly USA, LLC | 3 | $50 |
| EPI Health, LLC | 1 | $31 |
| Journey Medical Corporation | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Medtronic | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,070 in reported general payments places this provider in the 90th percentile of 950 medical providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 20 | $14,897 |
| Fluocinonide | 28 | $1,143 |
| Clobetasol Propionate | 20 | $682 |
| Clindamycin Phosphate | 17 | $515 |
| Doxycycline Hyclate | 20 | $475 |
| Triamcinolone Acetonide | 60 | $363 |
| Doxycycline Monohydrate | 17 | $272 |
| Ketoconazole | 27 | $245 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 14 | $185 |
| Mupirocin | 16 | $125 |
| Hydrocortisone | 35 | $123 |
| Minoxidil | 11 | $122 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $149 | $14,89720 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 950 medical providers in Georgia.
Other medical in Roswell
- Felicia HoffmanRoswell$114K
- Tomas ChaoWoodstock$1.9M
- Kimberly OrleckAtlanta$727K
- Audrey GibsonGainesville$302K
- Lisa WeissCanton$283K
- Laura BushFayetteville$146K
- Michael KelleherMarietta$126K
- Juliena GigonMarietta$122K
- Sally BrumbillLithia Springs$110K
- Danna Dennis-CalderAtlanta$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.